Vis enkel innførsel

dc.contributor.authorBørøsund, Elin
dc.contributor.authorEhlers, Shawna
dc.contributor.authorVarsi, Cecilie
dc.contributor.authorClark, Matthew M.
dc.contributor.authorAndrykowski, Michael A.
dc.contributor.authorCvancarova, Milada
dc.contributor.authorNes, Lise Solberg
dc.coverage.spatialNorwayen_US
dc.date.accessioned2021-06-11T13:05:32Z
dc.date.available2021-06-11T13:05:32Z
dc.date.created2020-05-26T13:39:52Z
dc.date.issued2020-04-03
dc.identifier.citationCancer Medicine. 2020, 9 (11), 3775-3785).en_US
dc.identifier.issn2045-7634
dc.identifier.urihttps://hdl.handle.net/11250/2759013
dc.description.abstractBackground: In-person cognitive-behavioral stress-management interventions are consistently associated with reduced cancer distress. However, face-to-face delivery is an access barrier for many patients, and there is a need to develop remote-delivered interventions. The current study evaluated the preliminary efficacy of an application (app)-based cancer stress-management intervention, StressProffen, in a randomized controlled trial. Methods: Cancer survivors, maximum 1-year posttreatment (N = 172), were randomized to StressProffen (n = 84) or a usual care control group (n = 88). Participants received a blended delivery care model: (a) one face-to-face introduction session, (b) 10 app-based cognitive-behavioral stress-management modules, and (c) follow-up phone calls at weeks 2-3 and 6-7. Outcome measures included stress (Perceived Stress Scale), anxiety and depression (Hospital Anxiety Depression Scale), and health-related quality of life (HRQoL; Short-Form Health Surveys [SF-36]) at 3-months post-intervention, analyzed with change scores as dependent variables in linear regression models. Results: Participants were primarily women (82%), aged 20-78 years (mean 52, SD 11.2), with mixed cancer types (majority breast cancer; 48%). Analysis of 149 participants completing questionnaires at baseline and 3 months revealed significant intervention effects: decreased stress (mean difference [MD] −2.8; 95% confidence interval [CI], [−5.2 to −0.4]; P = .022) and improved HRQoL (Role Physical MD = 17.7, [CI 3.7-31.3], P = .013; Social Functioning MD = 8.5, [CI 0.7-16.2], P = .034; Role Emotional MD = 19.5, [CI 3.7-35.2], P = .016; Mental Health MD = 6.7, [CI 1.7-11.6], P = .009). No significant changes were observed for anxiety or depression. Conclusions: Digital-based cancer stress-management interventions, such as StressProffen, have the potential to provide easily accessible, effective psychosocial support for cancer survivors.en_US
dc.language.isoengen_US
dc.publisherWileyen_US
dc.relation.ispartofseriesCancer Medicine;volume 9. issue 11
dc.rightsNavngivelse 4.0 Internasjonal*
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/deed.no*
dc.subjectCanceren_US
dc.subjectCancer survivorsen_US
dc.subjectDistressen_US
dc.subjectHealth-care deliveryen_US
dc.subjectPsycho-oncologyen_US
dc.subjectStress-managementen_US
dc.titleResults from a randomized controlled trial testing StressProffen; an application‐based stress‐management intervention for cancer survivorsen_US
dc.typePeer revieweden_US
dc.typeJournal articleen_US
dc.description.versionpublishedVersionen_US
dc.rights.holder© 2020 The Authors.en_US
cristin.ispublishedtrue
cristin.fulltextoriginal
cristin.qualitycode1
dc.identifier.doihttps://doi.org/10.1002/cam4.3000
dc.identifier.cristin1812665
dc.source.journalCancer Medicineen_US
dc.source.volume9en_US
dc.source.issue11en_US
dc.source.pagenumber10en_US
dc.relation.projectKreftforeningen: 4602492-2013en_US


Tilhørende fil(er)

Thumbnail

Denne innførselen finnes i følgende samling(er)

Vis enkel innførsel

Navngivelse 4.0 Internasjonal
Med mindre annet er angitt, så er denne innførselen lisensiert som Navngivelse 4.0 Internasjonal